EA009936B1 - Аэрозольная композиция для ингаляции, содержащая антихолинергическое средство - Google Patents

Аэрозольная композиция для ингаляции, содержащая антихолинергическое средство Download PDF

Info

Publication number
EA009936B1
EA009936B1 EA200500292A EA200500292A EA009936B1 EA 009936 B1 EA009936 B1 EA 009936B1 EA 200500292 A EA200500292 A EA 200500292A EA 200500292 A EA200500292 A EA 200500292A EA 009936 B1 EA009936 B1 EA 009936B1
Authority
EA
Eurasian Patent Office
Prior art keywords
acid
composition according
aqueous
drug composition
inhaler
Prior art date
Application number
EA200500292A
Other languages
English (en)
Russian (ru)
Other versions
EA200500292A1 (ru
Inventor
Фридрих Шмидт
Original Assignee
Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31979448&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA009936(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10237232A external-priority patent/DE10237232A1/de
Application filed by Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг filed Critical Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Publication of EA200500292A1 publication Critical patent/EA200500292A1/ru
Publication of EA009936B1 publication Critical patent/EA009936B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EA200500292A 2002-08-14 2003-07-25 Аэрозольная композиция для ингаляции, содержащая антихолинергическое средство EA009936B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10237232A DE10237232A1 (de) 2002-08-14 2002-08-14 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE10240257 2002-08-31
PCT/EP2003/008221 WO2004022052A1 (de) 2002-08-14 2003-07-25 Aerosolformulierung für die inhalation enthaltend ein anticholinergikum

Publications (2)

Publication Number Publication Date
EA200500292A1 EA200500292A1 (ru) 2005-10-27
EA009936B1 true EA009936B1 (ru) 2008-04-28

Family

ID=31979448

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500292A EA009936B1 (ru) 2002-08-14 2003-07-25 Аэрозольная композиция для ингаляции, содержащая антихолинергическое средство

Country Status (31)

Country Link
EP (2) EP1908468A1 (enExample)
JP (1) JP4602767B2 (enExample)
KR (1) KR101060972B1 (enExample)
CN (1) CN1674887A (enExample)
AT (1) ATE400265T1 (enExample)
AU (1) AU2003298473B9 (enExample)
BR (1) BR0313457A (enExample)
CA (1) CA2495275C (enExample)
CY (1) CY1108776T1 (enExample)
DE (1) DE50310117D1 (enExample)
DK (1) DK1530464T3 (enExample)
EA (1) EA009936B1 (enExample)
EC (1) ECSP055600A (enExample)
ES (1) ES2305479T3 (enExample)
HR (1) HRP20050132A2 (enExample)
IL (1) IL166814A (enExample)
MX (1) MXPA05001595A (enExample)
MY (1) MY142579A (enExample)
NO (1) NO20051287L (enExample)
NZ (1) NZ538743A (enExample)
PE (1) PE20040372A1 (enExample)
PL (1) PL375511A1 (enExample)
PT (1) PT1530464E (enExample)
RS (1) RS51396B (enExample)
SA (1) SA03240265B1 (enExample)
SI (1) SI1530464T1 (enExample)
TW (1) TWI317279B (enExample)
UA (1) UA81775C2 (enExample)
UY (1) UY27938A1 (enExample)
WO (1) WO2004022052A1 (enExample)
ZA (1) ZA200410325B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004038885A1 (de) * 2004-08-10 2006-02-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005001297A1 (de) * 2005-01-12 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055960A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055958A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
US10508280B2 (en) 2014-01-31 2019-12-17 AgBiome, Inc. Modified biological control agents and their uses
US9877486B2 (en) 2014-01-31 2018-01-30 AgBiome, Inc. Methods of growing plants using modified biological control agents
HUE058904T2 (hu) 2014-05-07 2022-09-28 Boehringer Ingelheim Int Porlasztókészülék
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
CA2948071C (en) 2014-05-07 2022-08-30 Boehringer Ingelheim International Gmbh Container, nebulizer and use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001089480A1 (en) * 2000-05-22 2001-11-29 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
WO2002032899A1 (de) * 2000-10-14 2002-04-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung
WO2003057694A1 (de) * 2002-01-12 2003-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur herstellung von scopinestern

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE10063957A1 (de) * 2000-12-20 2002-06-27 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001089480A1 (en) * 2000-05-22 2001-11-29 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
WO2002032899A1 (de) * 2000-10-14 2002-04-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung
WO2003057694A1 (de) * 2002-01-12 2003-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur herstellung von scopinestern

Also Published As

Publication number Publication date
WO2004022052A1 (de) 2004-03-18
ES2305479T3 (es) 2008-11-01
KR101060972B1 (ko) 2011-09-01
CA2495275A1 (en) 2004-03-18
CA2495275C (en) 2012-04-17
BR0313457A (pt) 2005-06-21
MY142579A (en) 2010-12-15
EP1530464B1 (de) 2008-07-09
PE20040372A1 (es) 2004-08-03
DK1530464T3 (da) 2008-09-08
PL375511A1 (en) 2005-11-28
SI1530464T1 (sl) 2008-12-31
JP4602767B2 (ja) 2010-12-22
AU2003298473A1 (en) 2004-03-29
ATE400265T1 (de) 2008-07-15
NO20051287D0 (no) 2005-03-11
IL166814A0 (en) 2006-01-15
PT1530464E (pt) 2008-08-28
EP1908468A1 (de) 2008-04-09
HRP20050132A2 (en) 2006-05-31
EP1530464A1 (de) 2005-05-18
TW200406213A (en) 2004-05-01
IL166814A (en) 2010-11-30
DE50310117D1 (de) 2008-08-21
NO20051287L (no) 2005-03-11
RS51396B (sr) 2011-02-28
KR20050049478A (ko) 2005-05-25
UY27938A1 (es) 2004-03-31
ECSP055600A (es) 2005-04-18
TWI317279B (en) 2009-11-21
AU2003298473B9 (en) 2011-06-09
CY1108776T1 (el) 2014-04-09
CN1674887A (zh) 2005-09-28
RS20050074A (sr) 2007-09-21
SA03240265B1 (ar) 2009-11-10
ZA200410325B (en) 2006-10-25
NZ538743A (en) 2006-05-26
MXPA05001595A (es) 2005-04-25
JP2006506345A (ja) 2006-02-23
EA200500292A1 (ru) 2005-10-27
UA81775C2 (uk) 2008-02-11
AU2003298473B2 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
AU2004275490B2 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
US7611694B2 (en) Aerosol formulation for inhalation comprising an anticholinergic
JP4602767B2 (ja) 抗コリン作用薬を含有する吸入用エアロゾル製剤
EA009989B1 (ru) Лекарственное средство и его применение для лечения воспалительных и/или обструктивных заболеваний дыхательных путей
US20090075990A1 (en) Aerosol Formulation for Inhalation Containing an Anticholinergic Agent
US20090317337A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
US20090306065A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
US20060034775A1 (en) Aerosol formulation for inhalation containing an anticholinergic
US20090170839A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
US20090221626A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
EA007228B1 (ru) Аэрозольная композиция для ингаляции, содержащая соль тиотропия
US20060153777A1 (en) Aerosol formulation for inhalation containing an anticholinergic

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU